Clinical Characteristics and Overall Survival Among Acute Myeloid Leukemia (AML) Patients with TP53 Gene Mutation (TP53m) or Chromosome 17p Deletion (17p del)

被引：1

作者：

Daver, Naval ^{[1
]}

Iqbal, Shahed ^{[2
]}

Huang, Julie ^{[2
]}

Renard, Camille ^{[2
]}

Lin, Joyce ^{[2
]}

Pan, Harry ^{[2
]}

Xing, Guan ^{[2
]}

Pan, Yang ^{[2
]}

Ramsingh, Giri ^{[2
]}

机构：

[1] MD Anderson Canc Ctr, Houston, TX USA

[2] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-170298

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1445 / 1446

页数：2

共 50 条

[21] Aberrant Nuclear p53 Expression Predicts Hemizygous 17p (TP53) Deletion in Chronic Lymphocytic Leukemia
Chang, Hong
Jiang, Allan M.
Qi, Connie X. Y.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 133 (01) : 70 - 74
[22] The gene expression signature associated with TP53 mutation/deletion in chronic lymphocytic leukaemia is dominated by the under-expression of TP53 and other genes on chromosome 17p
Lin, Ke
Lane, Brian
Carter, Anthony
Johnson, Gillian G.
Onwuazor, Obiageli
Oates, Melanie
Zenz, Thorsten
Stilgenbauer, Stephan
Atherton, Mark
Douglas, Angela
Ebrahimi, Bahram
Sherrington, Paul D.
Pettitt, Andrew R.
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 160 (01) : 53 - 62
[23] TP53 mutation and 17p deletion are associated with poor survival in patients with CLL irrespective of the inactivation of the other allele by deletion or TP53 mutation:: Results from a single center analysis
Zenz, T.
Haebe, S.
Kroeber, A.
Benner, A.
Kienle, D.
Buehler, A.
Denzel, T.
Winkler, D.
Doehner, H.
Stilgenbauer, S.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 35 - 35
[24] TP53 GENE-MUTATIONS AND 17P DELETIONS IN HUMAN ASTROCYTOMAS
CHUNG, R
WHALEY, J
KLEY, N
ANDERSON, K
LOUIS, DN
MENON, A
HETTLICH, C
FREIMAN, R
HEDLEYWHYTE, ET
MARTUZA, R
JENKINS, R
YANDELL, D
SEIZINGER, BR
GENES CHROMOSOMES & CANCER, 1991, 3 (05): : 323 - 331
[25] Overall survival among patients diagnosed with B-chronic lymphocytic leukemia with 17p deletion status (del(17p))
Katalinic, D.
Toetome, L.
Bildat, S.
Kattner, E.
Aleric, I.
Vcev, A.
ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 223 - 223
[26] Prognostic Impact of TP53 Mutation in Combination with Chromosome 17p Deletion in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Yun, Seongseok
Sandoval-Sus, Jose
Knepper, Todd C.
Teer, Jamie
Chavez, Julio C.
Pinilla-Ibarz, Javier
BLOOD, 2017, 130
[27] Multiple Myeloma with a Deletion of Chromosome 17p: TP53 Mutations Are Highly Prevalent and Negatively Affect Prognosis
Bruinink, Davine Hofste Op
Remco, Hoogenboezem
Sanders, Mathijs A.
Wardell, Christopher P.
Ashby, Cody
Bindels, Eric M. J.
Erpelinck-Verschueren, Claudia
van Strien, Paulette
Koenders, Jasper
Kavelaars, Francois G.
He, Jie
Bailey, Mark
Mughal, Tariq I.
Misund, Kristine
Beverloo, Berna
van der Holt, Bronno
Touw, Ivo
Waage, Anders
Avet-Loiseau, Herve
Jackson, Graham H.
Morgan, Gareth J.
Walker, Brian A.
Sonneveld, Pieter
BLOOD, 2016, 128 (22)
[28] Pediatric brain tumors:: Loss of heterozygosity at 17p and TP53 gene mutations
Orellana, C
Hernandez-Martí, M
Martínez, F
Castel, V
Millán, JM
Alvarez-Garijo, JA
Prieto, F
Badía, L
CANCER GENETICS AND CYTOGENETICS, 1998, 102 (02) : 93 - 99
[29] TP53 Protein Expression, But Not 17p13 Deletion, is Useful in Rapid Screening and Triage of TP53 Mutation in Acute Myeloid Leukemia
Nwaoduah, Nneamaka
Bernabeu, Belen Quereda
Wang, Zixuan
Liu, Jinglan
Uppal, Guldeep
Peiper, Stephen
Gong, Jerald
MODERN PATHOLOGY, 2018, 31 : 541 - 541
[30] TP53 Protein Expression, But Not 17p13 Deletion, is Useful in Rapid Screening and Triage of TP53 Mutation in Acute Myeloid Leukemia
Nwaoduah, Nneamaka
Bernabeu, Belen Quereda
Wang, Zixuan
Liu, Jinglan
Uppal, Guldeep
Peiper, Stephen
Gong, Jerald
LABORATORY INVESTIGATION, 2018, 98 : 541 - 541

← 1 2 3 4 5 →